Citation: Tc. Kloosterman et al., ELIMINATION OF HUMAN HEMATOLOGIC MALIGNANCIES BY HUMAN CYTOTOXIC EFFECTOR-CELLS IN IMMUNE-DEFICIENT (SCID) MICE, Experimental hematology, 23(8), 1995, pp. 803-803
Authors:
KLOOSTERMAN TC
MARTENS ACM
VANBEKKUM DW
HAGENBEEK A
Citation: Tc. Kloosterman et al., GRAFT-VERSUS-LEUKEMIA IN RAT MHC-MISMATCHED BONE-MARROW TRANSPLANTATION IS MERELY AN ALLOGENEIC EFFECT, Bone marrow transplantation, 15(4), 1995, pp. 583-590
Authors:
KLOOSTERMAN TC
MARTENS ACM
OSTERWALDER B
HAGENBEEK A
Citation: Tc. Kloosterman et al., INTERLEUKIN-2 THERAPY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOCYTIC-LEUKEMIA - STUDIES IN A RELEVANT RAT MODEL FOR AML, Bone marrow transplantation, 14(6), 1994, pp. 965-973
Citation: Tc. Kloosterman et al., QUANTITATIVE STUDIES ON GRAFT-VERSUS-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN RAT MODELS FOR ACUTE MYELOCYTIC AND LYMPHOCYTIC-LEUKEMIA, Bone marrow transplantation, 14(1), 1994, pp. 15-22
Authors:
GAISER JF
KLOOSTERMAN TC
MARTENS ACM
HAGENBEEK A
Citation: Jf. Gaiser et al., INVITRO RESISTANCE OF THE BROWN NORWAY RAT ACUTE MYELOCYTIC-LEUKEMIA (BNML) TO LYMPHOKINE-ACTIVATED KILLER ACTIVITY, Leukemia, 7(5), 1993, pp. 736-741
Authors:
KLOOSTERMAN TC
BLOKLAND I
MARTENS ACM
HAGENBEEK A
Citation: Tc. Kloosterman et al., GRAFT-VERSUS-HOST DISEASE AND ITS ANTILEUKEMIC EFFECT - PRECLINICAL STUDIES, Experimental hematology, 21(8), 1993, pp. 1096-1096